<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4753</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">https://doi.org/10.31782/IJCRR.2023.151402</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>&#13;
	Curcumin - Bio Conjugates as Chemotherapeutics: A Computational Study&#13;
&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Baboo</surname><given-names>Ramesh</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>30</day><month>07</month><year>2023</year></pub-date><volume>4)</volume><issue/><fpage>2</fpage><lpage>5</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>&#13;
	Introduction: Numerous studies have shown that curcumin possesses multifunctional pharmacological properties inducing apoptosis in a variety of tumor cells.&#13;
	Aim/Objectve: It is very significant work to investigate the quantitative structure activity relationship (QSAR) and inhibition mechanisms of these curcumin-related compounds.&#13;
	Method: QSAR studies of curcumin-amino acid bioconjugates have been carried out for their chemotherapeutic or anticancer activity against skin cancer cells. Based on molecular descriptor calculated by DRAGON software for QSAR, some key structural factors responsible for chemotherapeutic activity of these compounds were revealed.&#13;
	Results: The results have provided some useful theoretical references for understanding the mechanism of action, designing new curcumin-related compounds with chemotherapeutic activity and were predicted their activities prior to synthesis.&#13;
	Conclusion: The curcumin - glutamoyl derivative appeared to be the most effective compound when tested for antiproliferative potential.&#13;
&#13;
</p></abstract><kwd-group><kwd>Curcumin</kwd><kwd> QSAR</kwd><kwd> Chemotherapeutics</kwd><kwd> Bio conjugates</kwd><kwd> Antiproliferative</kwd><kwd> Computation</kwd></kwd-group></article-meta></front></article>
